Spermatogenetic inhibition in men taking a combination of oral medroxyprogesterone acetate and percutaneous testosterone as a male contraceptive method.

@article{Soufir2011SpermatogeneticII,
  title={Spermatogenetic inhibition in men taking a combination of oral medroxyprogesterone acetate and percutaneous testosterone as a male contraceptive method.},
  author={J C Soufir and G{\'e}ri M{\'e}duri and Ahmed Ziyyat},
  journal={Human reproduction},
  year={2011},
  volume={26 7},
  pages={1708-14}
}
BACKGROUND We previously demonstrated in a small pilot study that oral medroxyprogesterone acetate and percutaneous testosterone (OMP/PT) induce reversible spermatogenesis suppression. The aims of this study were to determine the rate of spermatogenetic inhibition and recovery and to obtain preliminary data on efficacy for a larger population under OMP/PT. METHODS A total of 35 healthy men with normal spermiograms requesting male hormonal contraception were treated with OMP (20 mg/day) and PT… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 30 references

Contraceptive efficacy of a depot progestin and androgen combination in men.

The Journal of clinical endocrinology and metabolism • 2003
View 4 Excerpts
Highly Influenced

Efficiency of a male contraceptive association, oral medroxyprogesterone acetate-percutaneous testosterone

JC Soufir, A. Laporte
In Mario S (ed). IV International Congress of Andrology. Ares-Serono Symposia, • 1989
View 2 Excerpts
Highly Influenced

Male hormonal contraception: love's labour's lost?

The Journal of clinical endocrinology and metabolism • 2009
View 1 Excerpt

Similar Papers

Loading similar papers…